查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595330

苯酮尿症治療市場：按給藥途徑、產品和分銷分類 - 2025-2030 年全球預測

Phenylketonuria Treatment Market by Route of Administration (Oral, Parenteral), Product (Dietary Supplement, Drugs), Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年苯酮尿症治療市值為74234萬美元，預計2024年將達到84056萬美元，複合年成長率為13.32%，到2030年將達到178182萬美元。

苯酮尿症 (PKU) 的治療涉及一種罕見的遺傳性疾病，其特徵是氨基酸苯丙胺酸代謝失敗，如果不治療，可能會導致嚴重的認知障礙。 PKU 治療市場的範圍涵蓋早期診斷和終身飲食管理等必需品，並輔以酵素替代療法和基因療法等藥物干預措施。應用圍繞著防止苯丙胺酸積聚的膳食產品和醫療食品，而新的藥物解決方案提供了變革性的方法。最終用途將主要集中在出生時診斷的嬰幼兒和兒童以及飲食受限的成年人，其中專科診所和醫院是關鍵接觸點。市場成長是由意識的提高、新生兒篩檢的增加以及治療技術的進步所推動的。新型療法的開發，包括 pegvariase 和基因療法的潛力，代表了潛在的成長機會，並支持藥物開發方面的策略夥伴關係，以擴大產品系列。然而，挑戰仍然存在，主要是與治療相關的高昂費用、資源匱乏地區的獲取機會有限以及影響患者生活品質的終生堅持飲食方案的複雜性。儘管有這些限制，生物工程酶和基因編輯等替代治療劑的動態性質正在為技術創新鋪平道路。創新的熱門領域包括開發更實惠、更容易取得的飲食管理產品、擴大現有藥物的適應症，以及透過先進的生物技術提高治療效果。進行全面的現實世界臨床試驗以了解縱向治療結果將極大地幫助相關人員應對這一複雜的情況。為了抓住快速成長的機遇，加強與學術機構和生技公司的策略聯盟可以加速將前沿研究轉化為可行的治療方法。最終，PKU 治療市場的特點是競爭和協作的環境，旨在提供具有成本效益和以患者為中心的解決方案，以普遍提高生活品質。

主要市場統計
基準年[2023] 74234萬美元
預測年份 [2024] 84056萬美元
預測年份 [2030] 1,781.82 百萬美元
複合年成長率（%） 13.32%

市場動態：快速發展的苯酮尿症治療市場的關鍵市場洞察

供需的動態交互作用正在改變苯酮尿症治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 苯酮尿症 (PKU) 疾病的發生率增加
    • 苯酮尿症治療期間和治療後的相關益處
    • 不斷進行提高人們對苯酮尿症認知的舉措
  • 市場限制因素
    • 不利的報銷政策
  • 市場機會
    • 基於管道藥物庫存的未來性
    • 基因組學和生物技術領域研究的成長
  • 市場挑戰
    • 與 PKU 治療相關的整體高成本

波特五力：駕馭苯酮尿症治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解苯酮尿症治療市場的外部影響

外部宏觀環境因素在塑造苯酮尿症治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解苯酮尿症治療市場的競爭狀況

對苯酮尿症治療市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣苯酮尿症治療市場供應商的績效評估

FPNV 定位矩陣是評估苯酮尿症治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製苯酮尿症治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對苯酮尿症治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 苯酮尿症 (PKU) 疾病的發生率增加
      • 苯酮尿症治療期間和治療後的益處
      • 加大力度提高人們對 PKU 症狀的認知
    • 抑制因素
      • 不利的退款政策
    • 機會
      • 管道藥物庫存的未來性
      • 基因組學和生物技術領域的研究進展
    • 任務
      • PKU 治療相關的總體成本較高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章苯酮尿症治療市場：依給藥途徑

  • 口服
  • 胃腸外的

第7章苯酮尿症治療市場：依產品

  • 食品補充品
  • 藥品
    • 生物膜
    • 庫萬

第8章苯酮尿症治療市場經銷商

  • 藥局
  • 醫院藥房
  • 網路藥房
  • 小兒科診所

第9章 北美和南美苯酮尿症治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區苯酮尿症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲苯酮尿症治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Ajinomoto Cambrooke, Inc.
  • American Gene Technologies International Inc.
  • BioMarin Pharmaceutical Inc.
  • BioMarin Pharmaceuticals, Inc.
  • Codexis, Inc.
  • Daiichi Sankyo Company, Limited
  • ERYTECH Pharma SA
  • Homology Medicines, Inc.
  • Nutricia by Danone
  • PTC Therapeutics
  • Reckitt Benckiser Group PLC
  • Rubius Therapeutics, Inc.
  • Synlogic, Inc.
  • Ultragenyx Pharmaceutical
  • Ultragenyx Pharmaceutical Inc.
Product Code: MRR-030EE485160A

The Phenylketonuria Treatment Market was valued at USD 742.34 million in 2023, expected to reach USD 840.56 million in 2024, and is projected to grow at a CAGR of 13.32%, to USD 1,781.82 million by 2030.

Phenylketonuria (PKU) treatment pertains to addressing a rare genetic disorder characterized by the inability to metabolize phenylalanine, an amino acid, potentially leading to severe cognitive impairment if untreated. The scope of the PKU treatment market spans necessities such as early diagnosis and lifelong dietary management, complemented by pharmaceutical interventions like enzyme replacement therapies and gene therapy prospects. The application largely revolves around dietary products and medical foods preventing phenylalanine accumulation, while emerging pharmaceutical solutions offer a transformative approach. End-use primarily focuses on infants diagnosed at birth, children, and adults under dietary restrictions, with specialist clinics and hospitals as critical touchpoints. Market growth is fueled by rising awareness, increased newborn screening, and technological advancements in treatment methodologies. The development of novel therapeutics, including pegvaliase and potential gene therapies, signifies potential growth opportunities, encouraging strategic partnerships in drug development for expanded product portfolios. However, challenges persist, primarily due to high costs associated with treatment and limited access in resource-constrained regions, coupled with cumbersome lifelong dietary adherence impacting patient quality of life. Despite these limitations, the dynamic nature of surrogate therapeutics, such as bioengineered enzymes and gene editing, paves the way for innovation. The top innovation areas include developing more affordable and accessible dietary management products, expanding indications for existing pharmaceuticals, and enhancing therapeutic efficacy through advanced biotechnology. Conducting comprehensive, real-world studies to capture longitudinal treatment outcomes can greatly aid stakeholders in navigating this complex landscape. To capture burgeoning opportunities, bolstering strategic alliances with academic institutions and biotech companies can spur the translation of cutting-edge research into viable treatments. Ultimately, the PKU treatment market is characterized by a competitive yet collaborative environment, aiming for cost-effective, patient-centric solutions to improve life quality universally.

KEY MARKET STATISTICS
Base Year [2023] USD 742.34 million
Estimated Year [2024] USD 840.56 million
Forecast Year [2030] USD 1,781.82 million
CAGR (%) 13.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Phenylketonuria Treatment Market

The Phenylketonuria Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of phenylketonuria (PKU) disorders
    • Benefits associated with ongoing and after the phenylketonuria treatment
    • Rising initiatives for the awareness of the PKU condition
  • Market Restraints
    • Unfavorable reimbursement policies
  • Market Opportunities
    • Future potential due to stock of pipeline drugs
    • Growing research in the field of genomics and biotechnology
  • Market Challenges
    • Overall high cost associated with PKU treatment

Porter's Five Forces: A Strategic Tool for Navigating the Phenylketonuria Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Phenylketonuria Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Phenylketonuria Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Phenylketonuria Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Phenylketonuria Treatment Market

A detailed market share analysis in the Phenylketonuria Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Phenylketonuria Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Phenylketonuria Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Phenylketonuria Treatment Market

A strategic analysis of the Phenylketonuria Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Phenylketonuria Treatment Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Cambrooke, Inc., American Gene Technologies International Inc., BioMarin Pharmaceutical Inc., BioMarin Pharmaceuticals, Inc., Codexis, Inc., Daiichi Sankyo Company, Limited, ERYTECH Pharma S.A., Homology Medicines, Inc., Nutricia by Danone, PTC Therapeutics, Reckitt Benckiser Group PLC, Rubius Therapeutics, Inc., Synlogic, Inc., Ultragenyx Pharmaceutical, and Ultragenyx Pharmaceutical Inc..

Market Segmentation & Coverage

This research report categorizes the Phenylketonuria Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on Product, market is studied across Dietary Supplement and Drugs. The Drugs is further studied across Biopten and Kuvan.
  • Based on Distribution, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Pediatric Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of phenylketonuria (PKU) disorders
      • 5.1.1.2. Benefits associated with ongoing and after the phenylketonuria treatment
      • 5.1.1.3. Rising initiatives for the awareness of the PKU condition
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Future potential due to stock of pipeline drugs
      • 5.1.3.2. Growing research in the field of genomics and biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Overall high cost associated with PKU treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Phenylketonuria Treatment Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Parenteral

7. Phenylketonuria Treatment Market, by Product

  • 7.1. Introduction
  • 7.2. Dietary Supplement
  • 7.3. Drugs
    • 7.3.1. Biopten
    • 7.3.2. Kuvan

8. Phenylketonuria Treatment Market, by Distribution

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies
  • 8.5. Pediatric Clinics

9. Americas Phenylketonuria Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Phenylketonuria Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Phenylketonuria Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Cambrooke, Inc.
  • 2. American Gene Technologies International Inc.
  • 3. BioMarin Pharmaceutical Inc.
  • 4. BioMarin Pharmaceuticals, Inc.
  • 5. Codexis, Inc.
  • 6. Daiichi Sankyo Company, Limited
  • 7. ERYTECH Pharma S.A.
  • 8. Homology Medicines, Inc.
  • 9. Nutricia by Danone
  • 10. PTC Therapeutics
  • 11. Reckitt Benckiser Group PLC
  • 12. Rubius Therapeutics, Inc.
  • 13. Synlogic, Inc.
  • 14. Ultragenyx Pharmaceutical
  • 15. Ultragenyx Pharmaceutical Inc.

LIST OF FIGURES

  • FIGURE 1. PHENYLKETONURIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PHENYLKETONURIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHENYLKETONURIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHENYLKETONURIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHENYLKETONURIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHENYLKETONURIA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY BIOPTEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY KUVAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 189. PHENYLKETONURIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. PHENYLKETONURIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023